Doug Hampton 
Ledatux is organizing its next workshop on the last Saturday of the month tomorrow, Saturday May 27, at its premises. The theme will be the use of tools to transfer large files → a one and a half hour film, dozens of photos… Regularly, messaging systems block the sending of files when they are too … Read more
VADUZ, Liechtenstein, May 26, 2023 /PRNewswire/ — Today, May 25, 2023, the annual general meeting (the “AGM”) of Implantica AG (publ) was held in Ruggel, Liechtenstein. The general meeting resolved to adopt all of the board of directors’ resolution proposals. A summary of the resolutions adopted at the general meeting is set out below. The general meeting … Read more
XI’AN, Chine, 26 mai 2023 /PRNewswire/ — Tianlong, une société innovante de haute technologie spécialisée dans les produits de diagnostic moléculaire en Chine, s’est associée à des hôpitaux publics du nord de la Thaïlande pour renforcer les mesures de détection de l’hépatite C (VHC) et de l’hépatite B (VHB), ainsi que pour le diagnostic et … Read more
SHANGHAI, 26 de mayo de 2023 /PRNewswire/ — BioRay Pharmaceutical Co., Ltd. (en adelante BioRay) anunció que la solicitud de Nuevo Fármaco en Investigación (IND) para el ensayo clínico de su BRY812 patentado, un nuevo conjugado de fármaco anticuerpo (ADC) dirigido al LIV-1 humano para el tratamiento de tumores malignos avanzados, ha sido aceptada por … Read more
DUBLIN, May 25, 2023 /PRNewswire/ — The “Generic Injectables Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to ResearchAndMarkets.com’s offering. The global generic injectable market is expected to grow at a CAGR of around 7.8% during 2023-2030. Companies Mentioned Hospira (Pfizer) Fresenius Kabi Hikma Pharma PLC Sandoz (Novartis) Sagent Inc. Sanofi … Read more
The TORCH-2 study is a Phase I/II trial of the mTORC1/2 inhibitor ATG-008 plus the Anti-PD-1 monoclonal antibody toripalimab for the treatment of patients with advanced solid tumors The combination treatment produced an objective response rate (ORR ) of 52.4% in the advanced cervical cancer cohort (including 75% in PD-L1 positive and 41.7% in PD-L1 negative … Read more
CLEARWATER, Fla., May 25, 2023 /PRNewswire/ — BayCare Health System, the leading health care system in West Central Florida, today announced it has funded the purchase and installation of menstrual dispensers in Hillsborough County Title 1 middle schools, giving nearly 12,000 students free and unlimited access to feminine products in their school bathrooms. Title 1 … Read more
Overall sensitivity of early cancer detection for novel blood-based assay was 82% at 95% specificity; specific cancer detection rates include colorectal (96%), lung (85%), prostate (82%) and breast (73%) Results, which demonstrate the potential of Harbinger’s biology-informed, AI-driven approach, currently being validated in 10,000-subject CORE-HH clinical trial with the Sarah Cannon Research Institute Findings published … Read more
Research Presented by Dr. Thomas Stricker Suggests Oncologists Should Switch to Targeted Treatment if Biomarker Testing Identifies Actionable Mutation Even After First-Line Treatment on Non-targeted treatment Has Begun Research Led by Dr. Gregory Vidal Evidences Identifies Inequities by Community Practice and Provider Levels in Accessing NGS Testing Among Black and Latinx Patients NASHVILLE, Tenn., May … Read more
DUBLIN, May 25, 2023 /PRNewswire/ — The “Angioscope Device Market – Forecasts from 2023 to 2028” report has been added to ResearchAndMarkets.com’s offering. The angioscope device market is projected to witness a compounded annual growth rate of 3.87% to grow to US$145.916 million by 2028, from US$111.843 million in 2021. Companies Mentioned LeMaitre Vascular, Inc. … Read more